MedDataX Logo

A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms

NCT ID: NCT00986219

Last Updated: 2009-12-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

696 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-09-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Asthma Language Symptoms, Limitation of Daily activities Patients Physicians Greece

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Asthma Language between patients and physicians

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time

Exclusion Criteria

* Patient with a cardiac disease (congestive heart failure, coronary heart disease)
* Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mina Gaga, MD

Role: PRINCIPAL_INVESTIGATOR

Director of the 7th Respiratory Clinic, Sotiria Hospital, Athens, Greece

Panagiotis Pontikis, Dr.

Role: STUDY_DIRECTOR

Marketing Company Medical Director, AstraZeneca Greece

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Pátrai, Achaia, Greece

Site Status

Research Site

Agrinio, Aitoloakarnanias, Greece

Site Status

Research Site

Thérmo, Aitoloakarnanias, Greece

Site Status

Research Site

Naupaktos, Aitoloakarnania, Greece

Site Status

Research Site

Argos, Argolida, Greece

Site Status

Research Site

Arta, Artas, Greece

Site Status

Research Site

Athens, Attica, Greece

Site Status

Research Site

Peraious, Attica, Greece

Site Status

Research Site

Livadia, Biotias, Greece

Site Status

Research Site

Chalcis, Chalkida, Greece

Site Status

Research Site

Chalkidiki, Chalkidiki, Greece

Site Status

Research Site

Chania, Crete, Greece

Site Status

Research Site

Heraklion, Crete, Greece

Site Status

Research Site

Rethymno, Crete, Greece

Site Status

Research Site

Ermoupoli, Cyclades, Greece

Site Status

Research Site

Rhodes, Dodekanisou, Greece

Site Status

Research Site

Drama, Drammas, Greece

Site Status

Research Site

Kastoria, Florinas, Greece

Site Status

Research Site

Amfisa, Fokidos, Greece

Site Status

Research Site

Pírgos, Ilia, Greece

Site Status

Research Site

Véroia, Imathia, Greece

Site Status

Research Site

Ioannina, Ioanninon, Greece

Site Status

Research Site

Karditsa, Karditsis, Greece

Site Status

Research Site

Chrisoupoli, Kavalas, Greece

Site Status

Research Site

Kavala, Kavalas, Greece

Site Status

Research Site

Loutraki, Korinthia, Greece

Site Status

Research Site

Ptolemaida, Kozani, Greece

Site Status

Research Site

Ksanthi, Ksanthis, Greece

Site Status

Research Site

Lakonia, Lakonia, Greece

Site Status

Research Site

Larissa, Larisas, Greece

Site Status

Research Site

Farsala, Larrisa, Greece

Site Status

Research Site

Volos, Magnisia, Greece

Site Status

Research Site

Kalamata, Messinia, Greece

Site Status

Research Site

Katerini, Peierias, Greece

Site Status

Research Site

Edessa, Pella, Greece

Site Status

Research Site

Komotini, Rodopi, Greece

Site Status

Research Site

Serres, Serron, Greece

Site Status

Research Site

Igoumenitsa, Thesprotia, Greece

Site Status

Research Site

Thessaloniki, Thessalonikis, Greece

Site Status

Research Site

Trikala, Trikalon, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RGR-DUM-2009/1

Identifier Type: -

Identifier Source: org_study_id